|Articles|June 1, 2003
Lentigo Maligna
San Francisco - In the United States surgery is the modality of choice for treatment of most primary as well as many recurrent lentigo maligna (LM), but there are a number of alternative options to consider for unresectable lesions, Glenn D. Goldman, M.D., said at the annual meeting of the American Academy of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Improving Outcomes in Acne, Hidradenitis Suppurativa, and Vitiligo Through Treatment Advancements
2
Expert Tips for Treating Vitiligo Shared at Elevate-Derm Conference
3
Treatment Plan Expectations and Previewing the 2026 Pipeline
4
Is It Just a Rash? Key Issues in Diagnosing and Treating Cutaneous Lupus
5















